ArticleESMO gastrointestinal oncology2026

Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapy.

A Ooki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.